Literature DB >> 21865584

G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium.

Andrei A Tica1, Erica C Dun, Oana S Tica, Xin Gao, Jeffrey B Arterburn, G Cristina Brailoiu, Tudor I Oprea, Eugen Brailoiu.   

Abstract

G protein-coupled estrogen receptor 1 (GPER), also named GPR30, has been previously identified in the female reproductive system. In this study, GPER expression was found in the female rat myometrium by reverse transcriptase-polymerase chain reaction and immunocytochemistry. Using GPER-selective ligands, we assessed the effects of the GPER activation on resting membrane potential and cytosolic Ca(2+) concentration ([Ca(2+)](i)) in rat myometrial cells, as well as on contractility of rat uterine strips. G-1, a specific GPER agonist, induced a concentration-dependent depolarization and increase in [Ca(2+)](i) in myometrial cells. The depolarization was abolished in Na(+)-free saline. G-1-induced [Ca(2+)](i) increase was markedly decreased by nifedipine, a L-type Ca(2+) channel blocker, by Ca(2+)-free or Na(+)-free saline. Intracellular administration of G-1 produced a faster and transitory increase in [Ca(2+)](i), with a higher amplitude than that induced by extracellular application, supporting an intracellular localization of the functional GPER in myometrial cells. Depletion of internal Ca(2+) stores with thapsigargin produced a robust store-activated Ca(2+) entry; the Ca(2+) response to G-1 was similar to the constitutive Ca(2+) entry and did not seem to involve store-operated Ca(2+) entry. In rat uterine strips, administration of G-1 increased the frequency and amplitude of contractions and the area under the contractility curve. The effects of G-1 on membrane potential, [Ca(2+)](i), and uterine contractility were prevented by pretreatment with G-15, a GPER antagonist, further supporting the involvement of GPER in these responses. Taken together, our results indicate that GPER is expressed and functional in rat myometrium. GPER activation produces depolarization, elevates [Ca(2+)](i) and increases contractility in myometrial cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865584      PMCID: PMC3213913          DOI: 10.1152/ajpcell.00501.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  50 in total

Review 1.  The physiological basis of uterine contractility: a short review.

Authors:  S Wray; S Kupittayanant; A Shmygol; R D Smith; T Burdyga
Journal:  Exp Physiol       Date:  2001-03       Impact factor: 2.969

2.  Multiple Trp isoforms implicated in capacitative calcium entry are expressed in human pregnant myometrium and myometrial cells.

Authors:  Ming Yang; Anupma Gupta; Sergiy G Shlykov; Rebecca Corrigan; Susan Tsujimoto; Barbara M Sanborn
Journal:  Biol Reprod       Date:  2002-09       Impact factor: 4.285

3.  Role of GPR30 in endometrial pathology after tamoxifen for breast cancer.

Authors:  Tanja Ignatov; Holm Eggemann; Andrzej Semczuk; Bobbie Smith; Joachim Bischoff; Albert Roessner; Serban D Costa; Thomas Kalinski; Atanas Ignatov
Journal:  Am J Obstet Gynecol       Date:  2010-10-20       Impact factor: 8.661

4.  Acidic NAADP-sensitive calcium stores in the endothelium: agonist-specific recruitment and role in regulating blood pressure.

Authors:  G Cristina Brailoiu; Bogdan Gurzu; Xin Gao; Raman Parkesh; Parvinder K Aley; Diana I Trifa; Antony Galione; Nae J Dun; Muniswamy Madesh; Sandip Patel; Grant C Churchill; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

Review 5.  Nongenomic action of steroids in myometrial contractility.

Authors:  M Perusquía
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

6.  Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.

Authors:  Gloria S Huang; Marc J Gunter; Rebecca C Arend; Maomi Li; Hugo Arias-Pulido; Eric R Prossnitz; Gary L Goldberg; Harriet O Smith
Journal:  Am J Obstet Gynecol       Date:  2010-06-03       Impact factor: 8.661

7.  Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.

Authors:  Edward J Filardo; Jeffrey A Quinn; A Raymond Frackelton; Kirby I Bland
Journal:  Mol Endocrinol       Date:  2002-01

Review 8.  Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.

Authors:  Edward J Filardo
Journal:  J Steroid Biochem Mol Biol       Date:  2002-02       Impact factor: 4.292

9.  Expression of capacitative calcium TrpC proteins in rat myometrium during pregnancy.

Authors:  Lidiya G Babich; Chun-Ying Ku; Hays W J Young; Helen Huang; Michael R Blackburn; Barbara M Sanborn
Journal:  Biol Reprod       Date:  2003-11-19       Impact factor: 4.285

10.  Effect of estrogen formulation and its site of deposition on serum PGFM concentrations, uterine contractility, and time of ovulation in artificially inseminated weaned sows.

Authors:  K L Willenburg; R V Knox; R N Kirkwood
Journal:  Anim Reprod Sci       Date:  2004-01       Impact factor: 2.145

View more
  19 in total

1.  The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner.

Authors:  Cheng Wang; Xiangmin Lv; Chao Jiang; John S Davis
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

Review 2.  GPER-novel membrane oestrogen receptor.

Authors:  Margaret A Zimmerman; Rebecca A Budish; Shreya Kashyap; Sarah H Lindsey
Journal:  Clin Sci (Lond)       Date:  2016-06-01       Impact factor: 6.124

Review 3.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

4.  G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells.

Authors:  Joseph B Altmann; Guang Yan; Jeffrey F Meeks; Mary E Abood; Eugen Brailoiu; G Cristina Brailoiu
Journal:  J Neurochem       Date:  2015-03-02       Impact factor: 5.372

Review 5.  G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis.

Authors:  Haifei Shi; Shiva Priya Dharshan Senthil Kumar; Xian Liu
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

6.  Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation.

Authors:  G Cristina Brailoiu; Khalid Benamar; Jeffrey B Arterburn; Erhe Gao; Joseph E Rabinowitz; Walter J Koch; Eugen Brailoiu
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182

7.  G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.

Authors:  Burcu Kasap; Nilgün Öztürk Turhan; Tuba Edgünlü; Müzeyyen Duran; Eren Akbaba; Gökalp Öner
Journal:  Bosn J Basic Med Sci       Date:  2016-01-06       Impact factor: 3.363

8.  Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.

Authors:  Justine Yu; Elena Deliu; Xue-Quian Zhang; Nicholas E Hoffman; Rhonda L Carter; Laurel A Grisanti; G Cristina Brailoiu; Muniswamy Madesh; Joseph Y Cheung; Thomas Force; Mary E Abood; Walter J Koch; Douglas G Tilley; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2013-06-27       Impact factor: 5.157

9.  Bradycardic effects mediated by activation of G protein-coupled estrogen receptor in rat nucleus ambiguus.

Authors:  G Cristina Brailoiu; Jeffrey B Arterburn; Tudor I Oprea; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  Exp Physiol       Date:  2012-10-26       Impact factor: 2.969

Review 10.  Estrogen biology: new insights into GPER function and clinical opportunities.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Mol Cell Endocrinol       Date:  2014-02-12       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.